Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Boundless Bio 10% Owner Kevin Tang Buys $51.6K of Stock
Kevin Tang, 10% Owner, bought 21,640 shares of Boundless Bio, Inc. at $2.38 to $2.40 a share (average $2.39) in 3 transactions, worth $51.6K in total between Oct 22, 2026 and Oct 26, 2026. Shares held after the trade: 3,011,749 (+0.3%).
Standex International Corporation appointed Brenna D. Preisser as a Class I director, effective January 1, 2027, succeeding the retiring B. Joanne Edwards. Ms. Preisser, currently an Executive Vice President at Brunswick Corporation, will receive a $150,000 restricted stock award and standard non-employee director compensation.
Genvor Incorporated entered into an Intellectual Property Assignment Agreement with its founder and Chief Scientific Officer, Dr. Jesse Jaynes. Dr. Jaynes assigned the rights to approximately 9,000 synthetic antimicrobial peptide sequences and associated validation data to the company for use in its research and commercialization programs.
Soren Acquisition Corp. implemented a planned leadership transition, appointing Joseph Tonnos as Chief Financial Officer and a director, succeeding Jamie Weber. Additionally, Roger Cloutier Jr. and Austin Criden were appointed to the board following the resignations of Spencer Gerrol and Charles N. Kahn III. These changes are part of a broader alignment with the Di Rezze Family Office, which sponsors the SPAC.
Mirum Pharmaceuticals announced positive results from Cohort 2 of its pivotal PROGRESS study evaluating ATEBRIOZ (zilurgisertib) in pediatric patients aged 6 to <12 with fibrodysplasia ossificans progressiva (FOP). The study met its endpoints with a significant reduction in total heterotopic ossification lesion volume and improved joint mobility compared to placebo, supporting a planned sNDA submission in the first half of 2027.
Kinetik Holdings subsidiary EagleClaw Midstream Ventures reached a settlement with Energy Transfer to resolve a dispute regarding the expiration date of an NGL purchase agreement. The parties confirmed the agreement will terminate on December 31, 2026, while a second agreement remains subject to ongoing litigation awaiting adjudication.
Longeveron announced updated Phase 2b ELPIS II trial results for laromestrocel in infants with hypoplastic left heart syndrome (HLHS). While the trial missed its primary efficacy endpoint of RVEF change, additional analysis showed the secondary endpoint of major adverse cardiac events (MACE) achieved statistical significance with only 1 event in the treatment arm versus 8 in the standard of care arm (P=0.043).
Capital City Bank Group Director William F. Butler Buys $20K of Stock
William F. Butler, Director, bought 392 shares of Capital City Bank Group Inc at $51.07 a share, worth $20K in total on Oct 26, 2026. Shares held after the trade: 7,137 (+5.8%).
Flexsteel Industries reported fiscal first quarter 2027 net sales of $114.0 million, a 3.2% increase year-over-year, driven by 5.1% growth in Flexsteel branded products. GAAP net income per diluted share was $1.24, down from $1.31 in the prior year quarter, impacted by foreign currency headwinds and rising ocean transportation and material costs.
Term
Q1 2027
“I'm pleased with our first quarter results and the continued momentum of our growth strategies despite a challenging macroeconomic environment. Net sales increased 3.2 percent compared to the prior year, toward the upper end of our guidance range, marking our twelfth consecutive quarter of year-over-year growth.”
Derek Schmidt, CEO of Flexsteel Industries, Inc.
“From a profitability standpoint, we delivered a GAAP operating margin of approximately 6 percent, which included a $0.8 million or 70 bps unfavorable foreign currency translation impact related to our peso-denominated asset exposure in Mexico.”
GrafTech International Ltd. finalized estimates for its previously announced permanent closure of its manufacturing facility in Monterrey, Mexico. The company expects to incur total non-cash charges of $25 million to $35 million, including $12.3 million in fixed asset write-offs, while maintaining its estimate of $20 million to $25 million in one-time cash expenditures.
Supernus Pharmaceuticals Deal Termination with UBS Bank USA
Supernus Pharmaceuticals terminated its uncommitted demand revolving credit line with UBS Bank USA on October 20, 2026. The termination was made in anticipation of the company's pending merger with Indivior Pharmaceuticals and the establishment of a new senior secured credit facility for the combined entity. There were no outstanding borrowings or early termination penalties associated with the cancellation.
Columbus McKinnon Corporation's Board of Directors declared a regular quarterly cash dividend of $0.07 per common share. The dividend is payable on November 16, 2026, to shareholders of record as of November 6, 2026.
CV Sciences has settled an arbitration case initiated in February 2025 against its former legal counsel. Under the settlement terms, the company received $500,000 and both parties have mutually released all claims against each other.
Cumberland Pharmaceuticals announced plans to submit a New Drug Application (NDA) for ifetroban to treat cardiomyopathy associated with Duchenne muscular dystrophy (DMD). The submission is supported by Phase 2 FIGHT DMD trial data showing a statistically significant 5.4% improvement in left ventricular ejection fraction (LVEF) compared to a control group. While the FDA expressed concerns regarding the sufficiency of the data package for efficacy requirements, the company is moving forward with the submission following a pre-NDA meeting.
Praetorian Acquisition Corp. implemented a planned leadership transition, appointing Joseph Tonnos as Chief Financial Officer and a director, succeeding Peter Ondishin. The company also appointed Roger L. Cloutier, Jimmy Vaiopoulos, and Charles P. Garcia to its board of directors following the resignations of Nicole Seligman, Erica Dorfman, and Alex Elias.
Bain Capital Private Credit declared a regular monthly distribution of $0.1875 per Class I share for shareholders of record as of October 30, 2026. The filing also disclosed a net asset value (NAV) per share of $26.03 as of September 30, 2026, and the sale of $57.0 million in unregistered shares to feeder vehicles.
Weave Communications Signs $650M M&A Deal with Francisco Partners
Weave Communications, Inc. completed its acquisition by Francisco Partners in an all-cash transaction valued at approximately $650 million. Under the terms of the deal, Weave stockholders received $7.40 per share, and the company has transitioned to a privately held entity, delisting from the New York Stock Exchange.
Value
$650M
Counterparty
Francisco Partners
“Today marks the start of an exciting new chapter for Weave. For nearly two decades, Weave has built solutions for independent practices caring for patients in communities across the country. Today, more than 40,000 locations rely on us to deepen their relationship with patients through automated communication and engagement solutions. With Francisco Partners’ support and resources, we’re well positioned to deliver even more value to the practices we serve. I want to thank our employees, whose dedication made this milestone possible.”
Brett White, Chief Executive Officer of Weave
“Weave sits at the center of how tens of thousands of healthcare practices communicate with their patients and collect revenue. We are pleased to officially partner with Brett and the Weave team and see significant opportunity to build on that position through continued product innovation in AI-powered patient engagement and payments solutions.”
Atlantic Union Bankshares EVP Matthew L. Linderman Sells $310K of Stock
Matthew L. Linderman, EVP, sold 7,746 shares of Atlantic Union Bankshares Corp at $40.00 a share, worth $310K in total on Oct 22, 2026. Shares held after the trade: 10,455 (-42.6%).
FirstSun Capital Bancorp reported Q3 2026 net income of $38.4 million, or $0.82 per diluted share, reflecting improved net interest margins and operating synergies from its recent acquisition of First Foundation. The company also completed a core system conversion for First Foundation and repurchased $49.7 million of its own common stock during the quarter.
Term
Q3 2026
“Third quarter results reflect our continued progress on our strategic priorities highlighted by an improved net interest margin as a result of continued balance sheet improvements, a strong diversified revenue profile and improved earnings performance, including benefits from operating synergies realized following the acquisition of First Foundation in the second quarter.”
Neal Arnold, FirstSun’s Chief Executive Officer and President
“Additionally, in late September, we successfully completed the core system conversion of First Foundation, representing another important milestone in our overall integration plan. I'm extremely proud of our teammates for all the hard work, planning and collaboration in completing the conversion while continuing to serve our great clients throughout the process.”
Neal Arnold, FirstSun’s Chief Executive Officer and President
TrueBlue, Inc. has appointed Elizabeth Castro Gulacsy to its Board of Directors and its Audit Committee, effective October 26, 2026. Ms. Castro Gulacsy, the former CFO of United Parks & Resorts, joins as an independent director as part of a board refreshment process and a previously disclosed cooperation agreement with EHS Management. Her appointment increases the total number of directors on the TrueBlue board to ten.
HPS Corporate Lending Fund declared regular and variable supplemental distributions for October 2026 across all share classes, payable to shareholders of record as of October 31, 2026. The total net distribution for Class I shares is $0.1990 per share, with payments expected on or about November 30, 2026. The Fund also reported a net asset value (NAV) of $24.45 per share for all classes as of September 30, 2026.
NewHydrogen, Inc. entered into a securities purchase agreement with SunHydrogen, Inc. to raise approximately $3 million through the issuance of 203,650,000 shares of common stock and warrants to purchase an additional 407,300,000 shares. The common stock was priced at $0.01473 per share, and the proceeds are intended for general corporate purposes and working capital.
North Haven Private Income Fund A M&A Deal with North Haven Private Income Fund LLC
North Haven Private Income Fund A LLC (PIF A) has entered into a definitive merger agreement to be acquired by North Haven Private Income Fund LLC (PIF). The transaction will be a NAV-for-NAV exchange where PIF A unitholders will receive Class I units of PIF, creating a combined entity with approximately $6.6 billion in total investments.
Counterparty
North Haven Private Income Fund LLC
“we are pleased with the Companies’ performance and believe the Merger will create value for investors, including through a reduced management fee. The Merger advances our long-standing strategic vision and better positions PIF to capitalize on the strength of the Morgan Stanley platform to scale further in the marketplace.”
Michael Occi, Chief Executive Officer of the Companies
D.R. Horton, Inc. appointed Carl E. Reichardt, Jr. to its Board of Directors as an independent director, effective October 22, 2026. Mr. Reichardt will receive an annual cash fee of $80,000, an annual RSU award valued at $235,000, and a one-time new director RSU grant valued at $250,000.
PennantPark Private Income Fund Capital Raise of $3.08M
PennantPark Private Income Fund issued and sold 118,703 common shares for aggregate proceeds of approximately $3.08 million on October 1, 2026. The sale was conducted as part of the company's ongoing continuous private offering to accredited investors. Additionally, the company reported a net asset value (NAV) per share of $25.95 as of September 30, 2026.
Applied Materials Partnership with BE Semiconductor Industries N.V.
Applied Materials entered into an accelerated share purchase agreement to increase its minority stake in BE Semiconductor Industries (Besi) to approximately 20%. The investment reinforces a long-term strategic partnership focused on co-innovating advanced packaging and hybrid bonding technologies for AI-driven semiconductor scaling.
H2O America reported operating revenue of $644.0 million for the nine months ended September 30, 2026, a 6.2% increase over the prior year. Net income for the same period rose to $88.6 million, supported by the recent acquisition of Quadvest's water and wastewater assets, though earnings per share decreased due to a higher weighted average share count.
Health In Tech appointed Sanjay Shrestha as Chief Executive Officer, succeeding founder Tim Johnson who transitioned to Executive Chairman. Mr. Shrestha's employment agreement includes a $500,000 base salary (increasing to $700,000 upon a $10M capital raise), eligibility for a cash bonus up to 200% of salary, and various equity awards.
North Haven Private Income Fund M&A Deal with North Haven Private Income Fund A LLC
North Haven Private Income Fund LLC (PIF) has entered into a definitive agreement to acquire North Haven Private Income Fund A LLC (PIF A) in a NAV-for-NAV exchange ratio merger. The combined entity is expected to have approximately $6.6 billion in total investments at fair value and will benefit from a reduced management fee of 1.00%. The transaction is expected to close in December 2026, subject to regulatory approvals and customary closing conditions.
Counterparty
North Haven Private Income Fund A LLC
“we are pleased with the Companies’ performance and believe the Merger will create value for investors, including through a reduced management fee. The Merger advances our long-standing strategic vision and better positions PIF to capitalize on the strength of the Morgan Stanley platform to scale further in the marketplace.”
Michael Occi, Chief Executive Officer of the Companies
Welltower Inc. reported Q3 2026 net income of $415 million, or $0.54 per diluted share, with normalized FFO increasing 24.6% year-over-year to $1.67 per share. The company achieved significant organic growth with total portfolio same-store NOI up 15.8%, driven by a 21.0% increase in its Seniors Housing Operating portfolio. Welltower also declared its 222nd consecutive quarterly cash dividend of $0.85 per share.